HLA Class II Immunogenetic Profiles Shape Psychosis Outcomes in Cannabis Users: DRB5/DRB1*16 Vulnerability and DRB4/DRB3-Linked Protection, Particularly Against Schizophrenia.

Buciuta A, Coman HG, Nemeș B, Cimpianu ME, Oroian R, Vică Matei ML, Matei HV

Open source

DOI
10.3390/neurosci7030056
Published
2026 May 7
Container
NeuroSci
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/neurosci7030056,
  title = {HLA Class II Immunogenetic Profiles Shape Psychosis Outcomes in Cannabis Users: DRB5/DRB1*16 Vulnerability and DRB4/DRB3-Linked Protection, Particularly Against Schizophrenia.},
  author = {Buciuta A and Coman HG and Nemeș B and Cimpianu ME and Oroian R and Vică Matei ML and Matei HV},
  year = {2026},
  journal = {NeuroSci},
  doi = {10.3390/neurosci7030056},
  url = {https://doi.org/10.3390/neurosci7030056}
}

RIS

TY  - JOUR
TI  - HLA Class II Immunogenetic Profiles Shape Psychosis Outcomes in Cannabis Users: DRB5/DRB1*16 Vulnerability and DRB4/DRB3-Linked Protection, Particularly Against Schizophrenia.
AU  - Buciuta A
AU  - Coman HG
AU  - Nemeș B
AU  - Cimpianu ME
AU  - Oroian R
AU  - Vică Matei ML
AU  - Matei HV
PY  - 2026
JO  - NeuroSci
DO  - 10.3390/neurosci7030056
UR  - https://doi.org/10.3390/neurosci7030056
ER  - 

APA

A, B., HG, C., B, N., ME, C., R, O., ML, V. M., & HV, M. (2026). HLA Class II Immunogenetic Profiles Shape Psychosis Outcomes in Cannabis Users: DRB5/DRB1*16 Vulnerability and DRB4/DRB3-Linked Protection, Particularly Against Schizophrenia.. NeuroSci. https://doi.org/10.3390/neurosci7030056

Source records